ICON PLC  

(Public, NASDAQ:ICLR)   Watch this stock  
Find more results for NASDAQ: ICLR
114.10
+1.42 (1.26%)
After Hours: 114.10 0.00 (0.00%)
Jan 23, 4:16PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 112.08 - 115.35
52 week 76.46 - 124.48
Open 112.17
Vol / Avg. 248,701.00/275,071.00
Mkt cap 6.17B
P/E 22.14
Div/yield     -
EPS 5.15
Shares 54.15M
Beta 0.61
Inst. own 101%
Feb 15, 2018
Full Year 2017 ICON PLC Earnings Call - 9:00AM EST - Add to calendar
Feb 15, 2018
Full Year 2017 ICON PLC Earnings Release Add to calendar
Jan 9, 2018
ICON PLC at JPMorgan Healthcare Conference - Webcast
Nov 15, 2017
ICON PLC at Jefferies Global Healthcare Conference
Nov 10, 2017
ICON PLC at Financial Times Global Pharmaceutical and Biotechnology Conference
Oct 26, 2017
Q3 2017 ICON PLC Earnings Call - Webcast
Oct 26, 2017
Q3 2017 ICON PLC Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin 16.84% 15.73%
Operating margin 19.29% 18.70%
EBITD margin - 22.77%
Return on average assets 15.03% 14.80%
Return on average equity 27.58% 30.70%
Employees 13,117 -
CDP Score - -

Address

South County Business Park, Dublin 18
DUBLIN, 00000
Ireland
+353-1-2912000 (Phone)
+353-1-2912700 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

ICON public limited company is a contract research organization (CRO), which is engaged in providing outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company is engaged in the strategic development, management and analysis of programs that support the various stages of the clinical development process, from compound selection to Phase I-IV clinical studies. Its services include clinical trials management, biometric activities, consulting, imaging, contract staffing, informatics and laboratory services. The Company's information systems offerings include ICONIK, Firecrest, ADDPLAN, AptivAdvantage and Aptiv Insite. It conducts various laboratory tests on the patient's blood, urine and other bodily fluids at appropriate intervals during the trial. The Company offers clinical development services, including investigator recruitment, patient registries, outcomes research, clinical data management, immunoassay development and others.

Officers and directors

Ciaran Murray Chairman of the Board
Age: 53
Bio & Compensation  - Reuters
Steve Cutler Chief Executive Officer, Director
Age: 54
Bio & Compensation  - Reuters
Brendan Brennan Chief Financial Officer
Age: 36
Bio & Compensation  - Reuters
Diarmaid Cunningham Executive Vice President, General Counsel, Secretary
Age: 40
Bio & Compensation  - Reuters
Hugh Brady Non-Executive Director
Age: 57
Bio & Compensation  - Reuters
John Climax Non-Executive Director
Age: 62
Bio & Compensation  - Reuters
Joan Garahy Non-Executive Director
Age: 54
Bio & Compensation  - Reuters
William W. Hall M.D., Ph.D. Non-Executive Director
Age: 65
Bio & Compensation  - Reuters
Ronan Lambe Ph.D. Non-Executive Director
Age: 75
Bio & Compensation  - Reuters